Contribution of PRF in CDH in Children With Prothetic Patch Closure
NCT ID: NCT03861182
Last Updated: 2021-01-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
30 participants
INTERVENTIONAL
2019-09-12
2019-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Child's Adipose Cells: Capacity of Tissue Regeneration
NCT02779205
StrataGraft Safety, Tolerability and Efficacy in Pediatric Subjects
NCT05517902
Case Series Assessing TissuGlu® Surgical Adhesive in Flap Surgery for Decubitus Repair
NCT03482999
Cutaneous Microcirculation After Remote Ischemic Preconditioning
NCT02417805
Effect of YAP1-inhibition in Surgical Wounds.
NCT06944249
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adult Healthy Volunteers
Biological functionalization of the prosthetic materials by PRF
The biological functionalization of the prosthetic materials by host PRF would improve the biological colonization of materials and thus reduce the risk of prosthetic release.
Neonates
Biological functionalization of the prosthetic materials by PRF
The biological functionalization of the prosthetic materials by host PRF would improve the biological colonization of materials and thus reduce the risk of prosthetic release.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biological functionalization of the prosthetic materials by PRF
The biological functionalization of the prosthetic materials by host PRF would improve the biological colonization of materials and thus reduce the risk of prosthetic release.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\- Over 18 years of age
Neonates:
* Aged between 1h of life and 28 days of life
* Born beyond 33 Week of Amenorrhea + 1day and 2kg of birth weight
* Hospitalized in the medical-surgical centre of Pediatrics of the hospital of Strasbourg
* For whom a blood sample was prescribed as part of their routine care
Exclusion Criteria
* Systemic inflammatory disease
* Transient inflammatory state
* Any drug that modifies the coagulation cascade during the 48h preceding the sampling
Neonates:
* Risk of anemia \< 7g/DL
* Current anticoagulant treatment
1 Day
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpitaux Universitaires de Strasbourg
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7067
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.